HOUSTON–(BUSINESS WIRE)–Murphy Oil Corporation (NYSE: MUR) today announced its financial and operating results for the…
Operations will Utilize Li-Cycle’s Patented Spoke Technology and will be Located On-Site at Ultium Cells’…
Agile pioneer to provide software delivery, full stack development and cloud support ARLINGTON, Va.–(BUSINESS WIRE)–#Agile—Excella,…
SAN FRANCISCO–(BUSINESS WIRE)–BizCap®, a national commercial finance and advisory firm, today announced it has successfully…
Slattery brings deep aviation and capital markets expertise to Vertical Aerospace Board LONDON & NEW…
Jessie Coan and Duncan Mills join to take the helm of corporate marketing and product…
Highly experienced diagnostics business development executive appointed to lead growth initiatives across international markets and…
LONDON, Jan. 27, 2022 (GLOBE NEWSWIRE) — Global Blood Therapeutics (GBT) today announced that the…
LONDON and BOSTON, Jan. 27, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB:…
Press Release Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2022…
Vancouver, British Columbia–(Newsfile Corp. – January 27, 2022) – Upco International Inc. (CSE: UPCO) (OTC…
The investment, led by Par Equity with Blumberg Capital, will fund product development and expansion…
Four Official Selections of the All-American High School Film Festival Showcased MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Thousands…
London, New York, Los Angeles 27th January 2022: Newsflare, the world’s leading licensing platform and…
New “neo bank” Leatherback is poised to disrupt the financial services sector with its one…
Partnership helps drive and increase growth for Mollie’s customers Amsterdam, 27 January 2022: Mollie, one…
27th January 2022 – London, UK – Crossword Cybersecurity Plc (AIM:CCS, “Crossword”, the “Company” or…
OSLO, Norway–(BUSINESS WIRE)–#AIVirtualProximitySensors—Elliptic Labs (EuroNext Growth: ELABS.OL), a global AI software company and the world…
WALLDORF, Germany–(BUSINESS WIRE)–SAP SE (NYSE: SAP) today announced its intent to acquire a majority stake…
Chinese Partner, 3D Medicines, Expects to Initiate Trial in Second Half of 2022 in Patients…